Another recurrent alteration involving SWI/SNF genes across various hematological malignancies is the gain or amplification of chromosome 2p16.1, which affects both BCL11A and the nearby REL gene, and which can lead to BCL11A overexpression in some cases [93, 126]. Here, BCL11A is linked to hematologic disorder.